SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-017079
Filing Date
2021-05-13
Accepted
2021-05-12 19:34:11
Documents
15
Period of Report
2021-05-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nt10023917x10_8k.htm   iXBRL 8-K 31507
2 EXHIBIT 5.1 nt10023917x10_ex5-1.htm EX-5.1 8037
7 nt10023817x10_ex5-1image01.jpg GRAPHIC 9519
  Complete submission text file 0001140361-21-017079.txt   229249

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlry-20210512.xsd EX-101.SCH 4129
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlry-20210512_def.xml EX-101.DEF 17066
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20210512_lab.xml EX-101.LAB 26163
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20210512_pre.xml EX-101.PRE 19209
8 EXTRACTED XBRL INSTANCE DOCUMENT nt10023917x10_8k_htm.xml XML 5855
Mailing Address 745 FIFTH AVENUE SUITE 1602 NEW YORK NY 10151
Business Address 745 FIFTH AVENUE SUITE 1602 NEW YORK NY 10151 519.322.8800
Tilray, Inc. (Filer) CIK: 0001731348 (see all company filings)

IRS No.: 824310622 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 21916657
SIC: 2833 Medicinal Chemicals & Botanical Products